Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
10/2010
10/20/2010EP2240462A1 Therapeutic compounds
10/20/2010EP2240448A1 Lactam inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
10/20/2010EP2240197A2 Use of a homeoprotein of the bicoid family for preventing or treating retinal ganglionic neurone degeneration
10/20/2010EP2240157A1 Ophthalmic preparations
10/20/2010EP1283832B1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
10/20/2010EP1206554B2 Activatable recombinant neurotoxins
10/20/2010CN101868455A Therapeutic substituted lactams
10/20/2010CN101868251A Pharmaceutical containing HIF-1alpha alpha and HIF-2alpha alpha expression inhibitor
10/20/2010CN101862420A Mixture for cleaning eyes
10/20/2010CN101862311A Penetration promoting and eyesight improving eye drop
10/20/2010CN101279027B Chinese medicine lotion preparation for curing acute conjunctivitis
10/19/2010US7816399 Synergistic combination of prostaglandin and nitric oxide donor compounds; ocular hypertension and glaucoma
10/19/2010US7816363 Inhibitors of histone deacetylase
10/19/2010US7816358 Pharmaceutical formulations comprising N,N′-disubstituted piperazine compounds
10/19/2010CA2585266C Ophthalmic compositions and methods of using the same
10/19/2010CA2464491C Conditioning solution for contact lenses
10/19/2010CA2399434C Isolation and transplantation of retinal stem cells
10/19/2010CA2362715C Quinazoline derivatives as angiogenesis inhibitors
10/19/2010CA2335913C Use of iso-osmotic saline solutions, method for preparing same and cerumenolytic medicines based on said solutions
10/14/2010WO2010117997A2 Peptide targeting of inner ear cells
10/14/2010WO2010117077A1 Therapeutic agent for chorioretinal diseases comprising sirolimus derivative as active ingredient
10/14/2010WO2010116270A1 Ep2/4 agonists
10/14/2010WO2010115491A2 Piperidine and piperazine derivatives as autotaxin inhibitors
10/14/2010WO2010062905A3 Lateral ventricle cell compositions and use for treating neural degenerative diseases
10/14/2010US20100261765 Mineralocorticoid receptor modulators
10/14/2010US20100261760 EP2 Receptor Agonists
10/14/2010US20100261748 Stable loratadine spill resistant formulation
10/14/2010US20100261718 N3 alkylated benzimidazole derivatives as mek inhibitors
10/14/2010US20100261717 N3 alkylated benzimidazole derivatives as mek inhibitors
10/14/2010US20100261715 Carbamate compounds which inhibit leukocyte adhesion mediated by vla-4
10/14/2010US20100261708 Diazepane Compounds Which Modulate The CB2 Receptor
10/14/2010US20100261706 Substituted tetracyclic 1h-indeno [1,2-b]pyridine-2(5h)-one analogs thereof and uses thereof
10/14/2010US20100261705 Carbostyril compound
10/14/2010US20100261652 Tissue Adhesive Using Engineered Proteins
10/14/2010US20100261641 Spiro-piperidine compounds and medicinal use thereof
10/14/2010US20100261271 Regulation of endogenous gene expression in cells using zinc finger proteins
10/14/2010US20100260835 Pharmaceutical composition
10/14/2010US20100260818 Stable medicated chewing gum comprising cyclodextrin inclusion complex
10/14/2010US20100260817 Polyamine Derivatives
10/14/2010US20100260784 Pai-1 binding modulators for the treatment of ocular disorders
10/14/2010US20100260782 NOVEL ANTI- Alpha 5 Beta 1 ANTIBODIES AND USES THEREOF
10/14/2010US20100260781 Treatment methods for autoimmune disorders
10/14/2010US20100260714 Compositions comprising n3 alkylated benzimidazole derivatives as mek inhibitors and methods of use thereof
10/14/2010CA2757368A1 Piperidine and piperazine derivatives as autotaxin inhibitors
10/13/2010EP2239270A2 Low molecular weight peptide derivatives as inhibitors of the Laminin/Nidogen interaction
10/13/2010EP2239253A1 Novel phenylpyrrole derivative
10/13/2010EP2238987A1 Sugar chain-related gene and use thereof
10/13/2010EP2238166A2 Use of anti-amyloid beta antibody in ocular diseases
10/13/2010EP2238126A2 Derivatives of tetrahydroquinoxaline urea, preparation thereof and therapeutic application thereof
10/13/2010EP2237785A2 Triarylmethane analogs and their use in treating cancers
10/13/2010EP2237777A2 Compositions and methods for treating neurodegenerative diseases
10/13/2010EP1765381B1 Treatment of neurological disorders with haematopoietic growth factors
10/13/2010EP1370537B1 Metalloproteinase inhibitors
10/13/2010CN1395581B Recombinant antibodies to human IL-1 beta
10/13/2010CN101861317A Antihistaminic and antiallergic agent and a method for the production thereof
10/13/2010CN101861187A Methods and compositions for treating dry eye
10/13/2010CN101857860A Application of viral nucleic acid sequence strictly conservative area as siRNA design template
10/13/2010CN101857594A Tetrahydropyridoindole compounds, and preparation method and application thereof
10/13/2010CN101856465A Chinese medicinal beverage for clearing heat, preventing heatstroke and improving eyesight and preparation method thereof
10/13/2010CN101856429A Medicine compound with visual fatigue relieving function and preparation method thereof
10/13/2010CN101856353A Medicinal composition using tolperisone optical isomer as active ingredient
10/13/2010CN101317847B Medicament composition for eyes or nose, and uses thereof
10/13/2010CN101278908B Eye drop capable of significantly increasing medicament effect
10/12/2010US7812169 Angiogenesis inhibitors; vision defects; anticancer agents; retinopathy; skin disorders; antiarthritic agents; antitumor agents; aids
10/12/2010US7811590 chimeric proteins; immunogens; from non-typeable Haemophilus influenzae or Moraxella catarrhalis, provides protective antigens in single molecule; inserting into surface exposed loops improves detection by immune system
10/12/2010US7811573 Targetting dendritic cells, endothelial cells, and macrophages which express integrins, to induce maturation
10/12/2010CA2480038C Substituted 4-aminocyclohexanols
10/12/2010CA2470578C Tetrahydroquinoline analogues as muscarinic agonists
10/12/2010CA2427352C Glycerophosphoinositol derivatives as modulators of cytosolic phospholipase
10/12/2010CA2416899C Method of treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract
10/12/2010CA2397964C Derivatives of partially desulphated glycosaminoglycans endowed with antiangiogenic activity and devoid of anticoagulating effect
10/12/2010CA2382317C Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage
10/07/2010WO2010114106A1 Monoclonal antibody capable of binding to specific discontinuous epitope occurring in ad1 region of human cytomegalovirus gb glycoprotein, and antigen-binding fragment thereof
10/07/2010WO2010114105A1 Monoclonal antibody capable of binding to ad2 region of human cytomegalovirus gb glycoprotein, and antigen-binding fragment thereof
10/07/2010WO2010113958A1 Pharmaceutical composition for treatment or prevention of ophthalmic diseases
10/07/2010WO2010113957A1 Pharmaceutical composition for treating or preventing glaucoma
10/07/2010WO2010113925A1 Composition for alleviating ultraviolet radiation-induced damage
10/07/2010WO2010113834A1 Pyrimidine compound
10/07/2010WO2010113753A1 Prophylactic or therapeutic agent for retinal diseases and method for preventing or treating retinal diseases, each comprising jnk (c-jun n-terminal kinase)-inhibiting peptide, and use of the peptide
10/07/2010WO2010113022A1 Plasminogen activator inhibitor-1 inhibitor
10/07/2010WO2010112615A1 Lysine derivatives functionalised with lipids
10/07/2010WO2010086828A3 Agonist anti-trkb monoclonal antibodies
10/07/2010WO2010079910A3 Eyesight-protecting composition containing functional components having preventive and therapeutic efficacy in diabetes or diabetes complications
10/07/2010WO2001079455A9 Kv10.1, A NOVEL VOLTAGE-GATED POTASSIUM CHANNEL FROM HUMAN BRAIN
10/07/2010US20100256229 Compositions of cholinesterase inhibitors
10/07/2010US20100256141 Novel bis-azaindole derivatives, preparation and pharmaceutical use thereof as kinase inhibitors
10/07/2010US20100256119 Azole derivatives and fused bicyclic azole derivatives as therapeutic agents
10/07/2010US20100255081 Method for treating symptoms of diabetes
10/07/2010US20100255061 Posterior Segment Drug Delivery
10/07/2010US20100255005 Gamma secretase modulators
10/07/2010US20100254992 Anti-mcp-1 antibodies, compositions, methods and uses
10/07/2010US20100254972 Methods for selecting protease resistant polypeptides
10/07/2010US20100254952 Isolated myeloid-like cell populations and methods of treatment therewith
10/07/2010US20100254934 Ophthalmic Compositions Comprising Povidone-Iodine
10/07/2010US20100254907 Methods for the treatment of tinnitus induced by cochlear excitotoxicity
10/07/2010CA2757615A1 Plasminogen activator inhibitor-1 inhibitor
10/07/2010CA2757396A1 Medical composition for treatment or prophylaxis of eye diseases
10/07/2010CA2757291A1 Medical composition for treatment or prophylaxis of glaucoma
10/07/2010CA2757188A1 Pyrimidine compound
10/07/2010CA2756889A1 Monoclonal antibody capable of binding to specific discontinuous epitope occurring in ad1 region of human cytomegalovirus gb glycoprotein, and antigen-binding fragment thereof
1 ... 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 ... 531